HONOLULU (KHON2) — Governor Josh Green, M.D. has signed an emergency proclamation to help improve emergency response time. On Friday, July 18, Gov. Green authorized Adjutant General, Brigadier General ...

Office of the Governor / slide deck . Gov. Josh Green, M.D., Commander in Chief of the Hawai‘i National Guard, today sig ...

"Following rigorous evaluation of the data, FDA decided that a marketing granted order for the Juul System was 'appropriate for the protection of public health' — the standard required by ...

In 2022, the FDA had made the decision to ban the products because the applications lacked sufficient evidence to show they met a public health standard.

The FDA issued an emergency use authorization to drug-maker Lilly for bamlanivimab, a monoclonal antibody that mimics the immune system’s response to infection with the virus that causes COVID-19.

Today’s authorization provides an additional COVID-19 vaccine option that meets the FDA’s standards for safety, effectiveness and manufacturing quality needed to support emergency use ...

The emergency use authorization continues until the health secretary ends it. Existing product authorizations can continue, and new ones, such as the updated COVID-19 vaccines, can be issued as ...

Pemgarda, made by Invivyd, is an infusion drug approved for use by patients who are immunocompromised to help protect against COVID-19 infection.

It is a protein-based vaccine, and such vaccines use harmless protein fragments of the virus to teach the immune system how to spot the virus and fight it off.

In December, the company said it had finished its final submission package to the FDA for emergency use authorization of the vaccine, called NVX-CoV2373.

Novavax asked the Food and Drug Administration on Monday to grant an emergency use authorization for its protein-based COVID-19 vaccine.